Agenda item

Report of the Director of Public Health

The Director of Public Health submitted a report (previously circulated) updating the Board of the progress and the latest draft of the Pharmaceutical Needs Assessment (PNA) (also previously circulated) prior to the commencement of the period of statutory consultation.

It was reported that a PNA describes the health needs of the population and the services delivered by community pharmacies which are in place, or could be commissioned to meet those identified health needs; and the Health and Wellbeing Board had a statutory duty to produce a PNA every three years.

The submitted report detailed the work already completed to develop and update the PNA; the statutory period of formal consultation had commenced on 1 July until 22 August; the PNA was required to be published by 30 September 2022; and the Board would have opportunity to review and sign off the final PNA before publication.

RESOLVED – (a) That the latest draft of the final Pharmaceutical Needs Assessment be reviewed by the Health and Wellbeing Board.

(b) That the period of statutory consultation be noted by the Health and Wellbeing Board.

(c) That the deadline of 30 September 2022 for final sign off of the final document prior to publication and adoption of the document, be noted.

REASONS – a) The production and publication of the PNA is a statutory duty of the HWBB under The NHS Act 2006 and the Health and Social Care Act 2012.

(b) The PNA expires in 2022 and a new one requires sign off no later than 30th

September 2022.

(c) The draft document has been updated to reflect the latest data and with the most up to date information.

(d) The final document for sign off will be updated to reflect the comments received from the consultees.